Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиYumanity Therapeutics Мультипликаторы 2011-2024 | YMTX
Мультипликаторы по годам Yumanity Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.2 | -0.1 | -0.7 | -3.1 | -10.9 | - | - | - | - | - | - | - | - |
P/S |
3.2 | 4.0 | 0.9 | 60.2 | - | - | - | - | - | - | - | - | - |
EPS |
-1.3 | -12.9 | -2.7 | -21.6 | -14.7 | -1.6 | -2.3 | -2.1 | -42.1 | -63.7 | - | - | - |
EV (Enterprise Value) |
19 млн | 7.55 млн | 22.7 млн | 228 млн | 426 млн | -28.8 млн | -29.7 млн | -18.6 млн | -13.8 млн | -8.79 млн | - | - | - |
EBITDA per Share |
-1.42 | -8.42 | -2.53 | -5.43 | -2.82 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-0.4 | -1.9 | -12.0 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.04 | 3.54 | - | - | - | - | - | - | - | - | ||
P/B |
5.7 | 1.7 | -0.7 | 3.2 | -3.7 | - | - | - | - | - | - | - | - |
P/CF |
-1.1 | -0.4 | -0.5 | -10.1 | -12.3 | - | - | - | - | - | - | - | - |
ROE % |
-487.85 | -1433.27 | 97.34 | 266.81 | 33.96 | - | - | - | - | - | - | - | - |
ROA % |
-137.14 | -363.68 | -88.50 | -50.06 | -177.26 | - | - | - | - | - | - | - | - |
ROCE % |
-544.05 | -938.77 | 91.38 | 258.20 | -237.47 | - | - | - | - | - | - | - | - |
Current Ratio |
1.4 | 1.4 | 0.5 | 2.0 | 3.3 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Yumanity Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.46 | 0.04 | -0.77 | - | -1.14 | -1.23 | -1.07 | - | -0.97 | -1.03 | -0.85 | - | -2.96 | -0.13 | -3.47 | -0.23 | -0.25 | -0.39 | -0.28 | -0.36 | -0.5 | -0.43 | -0.32 | -0.51 | -0.56 | -0.68 | -0.6 | -0.38 | -0.54 | -0.47 | -0.87 | -13.95 | -16.77 | 0.12 | -14.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.34 | -0.1 | -0.78 | - | -0.91 | -1.01 | -1.11 | - | -0.87 | -0.97 | -0.89 | - | -2.47 | -2.85 | -3.19 | -0.24 | -0.26 | -0.4 | -0.29 | -0.37 | -0.47 | -0.41 | -0.31 | -0.51 | -0.52 | -0.66 | -0.6 | -0.38 | -0.52 | -0.47 | -0.74 | -11.1 | -11.5 | -11.7 | -9.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
11403.59 | 11627.07 | 11652.41 | 86.25 | 55.58 | -0.33 | -56.25 | -73.84 | -85.20 | -65.89 | -52.87 | -37.05 | -24.14 | -33.36 | -53.04 | -62.88 | -48.63 | -44.17 | -25.62 | -12.14 | -58.81 | -62.97 | -74.08 | -86.37 | -78.43 | -71.37 | -57.84 | -45.71 | -28.94 | -9.19 | 8.04 | 23.16 | 17.95 | 11.43 | 5.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-156.01 | -164.06 | -182.03 | -89.83 | -104.09 | -44.28 | -57.15 | -36.53 | -42.09 | -33.39 | -26.60 | -18.13 | -85.47 | -95.06 | -112.62 | -123.13 | -68.21 | -66.59 | -54.34 | -45.42 | -50.06 | -54.25 | -64.42 | -75.50 | -68.78 | -62.87 | -51.26 | -40.85 | -60.65 | -86.55 | -112.03 | -133.98 | -103.85 | -66.13 | -30.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
11442.33 | 11609.32 | 11647.65 | 77.27 | 48.01 | -1.38 | -50.79 | -72.41 | -82.92 | -64.16 | -51.65 | -34.70 | -21.47 | -32.29 | -53.69 | -65.32 | -50.44 | -45.46 | -26.17 | -11.84 | -59.58 | -63.71 | -74.85 | -87.16 | -79.31 | -72.07 | -58.31 | -45.98 | -28.35 | -9.04 | 8.21 | 22.70 | 16.85 | 10.76 | 4.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.4 | 1.8 | 1.0 | 1.4 | 2.3 | - | 1.6 | 1.6 | 1.9 | 2.0 | 2.1 | 2.0 | 2.0 | 2.0 | 2.0 | 0.9 | 3.8 | 3.8 | 3.8 | 6.2 | 6.2 | 6.2 | 6.2 | 7.9 | 7.9 | 7.9 | 7.9 | 9.4 | 9.4 | 9.4 | 9.4 | 1.3 | 1.3 | 1.3 | 1.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | 526.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.4 | 53.2 | 57.3 | 61.6 | 15.0 | 35.5 | 3047.8 | 62.5 | 67.9 | 69.8 | 78.3 | 51.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | 526.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.4 | 53.2 | 57.3 | 61.6 | 15.0 | 35.5 | 3047.8 | 62.5 | 67.9 | 69.8 | 78.3 | 51.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | 526.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.4 | 53.2 | 57.3 | 61.6 | 15.0 | 35.5 | 3047.8 | 62.5 | 67.9 | 69.8 | 78.3 | 51.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD